v3.25.4
Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2025
Stockholders' Equity  
Dividends declared and paid

The following table reflects the dividends paid per share within the respective three-month periods:

Fiscal Year

  ​ ​ ​

2026

  ​ ​ ​

2025

Second fiscal quarter

$

0.120

$

0.120

First fiscal quarter

0.120

0.120

Schedule of share repurchases

The following table summarizes all treasury stock purchases during the periods presented (in thousands, except per share amounts):

Six Months Ended

December 31, 

  ​ ​ ​

2025

2024

Number of treasury shares acquired

37

36

Average cost per share

$

4.93

$

5.32

Total cost of treasury shares acquired

$

182

$

191

Schedule of Market-based Award Valuation Assumptions

For performance-based awards granted during the six months ended December 31, 2025 and 2024, the assumptions used in the Monte Carlo simulation valuations were as follows:

Six Months Ended

December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

Weighted average fair value of performance-based awards granted

$

4.36

$

3.90

Risk-free interest rate

3.55%

3.45%

Expected term in years

2.78

2.78

Expected volatility

40.6%

50.2%

Dividend yield

8.8%

8.4%

Schedule of restricted stock transactions

Unvested restricted stock awards as of December 31, 2025 consisted of the following:

Weighted

Number of

Average

Restricted

Grant-Date

Award Type

  ​ ​ ​

Shares

  ​ ​ ​

Fair Value

Time-vested awards

371,997

$

5.40

Performance-based awards

508,851

4.65

Unvested at December 31, 2025

880,848

$

4.97

Restricted Stock  
Stockholders' Equity  
Schedule of restricted stock transactions

The following table sets forth the restricted stock award transactions for the six months ended December 31, 2025:

Weighted

Weighted

Unamortized

Average

Number of

Average

Compensation

Remaining

Restricted

Grant-Date

Expense

Amortization

  ​ ​ ​

Shares

  ​ ​ ​

Fair Value

  ​ ​ ​

(In thousands)

  ​ ​ ​

Period (Years)

Unvested at June 30, 2025

670,285

$

5.58

$

2,196

1.6

Time-vested shares granted

214,423

4.75

Performance-based shares granted

186,709

4.36

Vested

(190,569)

6.30

Unvested at December 31, 2025

880,848

$

4.97

$

2,982

1.7

Contingent restricted stock grants  
Stockholders' Equity  
Schedule of restricted stock transactions

The following table sets forth contingent restricted stock unit transactions for the six months ended December 31, 2025:

Weighted

Unamortized

Average

Number of

Weighted Average

Compensation

Remaining

Restricted

Grant-Date

Expense

Amortization

 

  ​ ​ ​

Stock Units

  ​ ​ ​

Fair Value

  ​ ​ ​

(In thousands)

  ​ ​ ​

Period (Years)

Unvested at June 30, 2025

241,613

$

2.37

$

340

1.8

Unvested at December 31, 2025

241,613

$

2.37

$

236

1.3